Trial intelligence / Profile preview

Vaginal oestriol for prevention of radiation-related vaginal stenosis

ACTRN12621001366842Phase 2Recruiting

Sponsor
Western Sydney Local Health District
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of estriol in vaginal stenosis, sponsored by Western Sydney Local Health District. Primary endpoints: Feasibility, compliance and acceptability, Incidence of vaginal stenosis and 1 more. Started May 2014; status: recruiting.

02

Drugs

estriol
03

Conditions

vaginal stenosis

Beyond the preview

Go deeper on ACTRN12621001366842.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12621001366842.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call